DR. STEVEN JAMES FREEDMAN, M.D./PH.D.
Osteopathic Medicine in Philadelphia, PA
License number
Pennsylvania MD422363
Category
Osteopathic Medicine
Type
Hematology & Oncology
License number
Pennsylvania 158662
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
2
39TH & Market Streets - SUITE 105, Philadelphia, PA 19104
1250 Fairland Dr, Prospectville, PA 19002
1250 Fairland Dr, Prospectville, PA 19002
Phone
(215) 662-9960
Professional information
Dr. Steven J Freedman, Ambler PA - MD (Doctor of Medicine)
Specialties:
Hematology, Medical Oncology, Oncology
Address:
1250 Fairland Dr, Ambler 19002
Certifications:
Hematology, 2004, Internal Medicine, 2000, Medical Oncology, 2003
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Tufts University
Graduated: 1993
University Of California-San Francisco
Beth Israel Deaconess Med Ctr-Harvard U
Dana-Farber Cancer Inst
Tufts University
Graduated: 1993
University Of California-San Francisco
Beth Israel Deaconess Med Ctr-Harvard U
Dana-Farber Cancer Inst
Ret Tyrosine Kinase Inhibition
US Patent:
2009022, Sep 10, 2009
Filed:
Jan 22, 2007
Appl. No.:
12/223042
Inventors:
Carolyn A. Buser-Doepner - Harleysville PA, US
Steven J. Freedman - Ambler PA, US
Cheryl A. Pickett - Blue Bell PA, US
Steven J. Freedman - Ambler PA, US
Cheryl A. Pickett - Blue Bell PA, US
International Classification:
A61K 31/506, A61P 35/00, C12N 9/99
US Classification:
51425219, 435184
Abstract:
The present invention provides methods for inhibiting RET tyrosine kinase. Further, the present invention also provides methods of treating or preventing thyroid cancer.
Jak2 Tyrosine Kinase Inhibition
US Patent:
2009006, Mar 5, 2009
Filed:
Jan 22, 2007
Appl. No.:
12/223043
Inventors:
Carolyn A. Buser-Doepner - Harleysville PA, US
Steven J. Freedman - Ambler PA, US
Jackson B. Gibbs - Chalfont PA, US
Frank J. Giles - Bellaire TX, US
Christopher G. Marshall - Framingham MA, US
John R. Pollard - Oxfordshire, GB
Steven J. Freedman - Ambler PA, US
Jackson B. Gibbs - Chalfont PA, US
Frank J. Giles - Bellaire TX, US
Christopher G. Marshall - Framingham MA, US
John R. Pollard - Oxfordshire, GB
International Classification:
A61K 31/506, A61P 35/02
US Classification:
51425219
Abstract:
The present invention provides methods for inhibiting JAK2 tyrosine kinase. Further, the present invention also provides methods of treating or preventing myeloproliferative disorders.
Jak2 Tyrosine Kinase Inhibition
US Patent:
2010032, Dec 23, 2010
Filed:
Aug 5, 2010
Appl. No.:
12/850920
Inventors:
Carolyn A. Buser-Doepner - Harleysville PA, US
Steven J. Freedman - Ambler PA, US
Jackson B. Gibbs - Chalfont PA, US
Frank J. Giles - Bellaire TX, US
Christopher G. Marshall - Framingham MA, US
John R. Pollard - Abingdon, GB
Steven J. Freedman - Ambler PA, US
Jackson B. Gibbs - Chalfont PA, US
Frank J. Giles - Bellaire TX, US
Christopher G. Marshall - Framingham MA, US
John R. Pollard - Abingdon, GB
International Classification:
A61K 31/496, A61P 35/02, A61P 7/00, C12N 9/99
US Classification:
51425219, 435184
Abstract:
The present invention provides methods for inhibiting JAK2 tyrosine kinase. Further, the present invention also provides methods of treating or preventing myeloproliferative disorders.